Applied DNA Sciences Signs Enterprise-Wide Agreement With One of the Top Four U.S. Defense Contractors for SigNature DNA Marking
STONY BROOK, NY--(Marketwired - Oct 15, 2013) - Applied DNA Sciences, Inc. (OTCQB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today it has signed a ten-year option agreement with one of the top four U.S. defense contractors to purchase SigNature DNA® marking technology. The international aerospace and defense company currently intends to apply its unique SigNature DNA mark on FSC 5962 microcircuits in support of US Defense Logistics Agency acquisition requirement (DLAD) 52.211-9074.
As a global leader, this defense contractor or "Prime" provides key defense systems to the Defense Logistics Agency, as well as a wide variety of advanced systems to military services and other government and private sector customers.
As one path to counterfeit risk mitigation, DLA has adopted DNA marking -- a powerful preventative solution. Now, with the addition of one of the top Primes, the entire semiconductor supply chain, from the point of manufacture, to the inclusion in higher-level assemblies, can be protected with the forensic security that only SigNature DNA can offer.
This company is a high-tech leader and supports military services such as: Navy, Army, Air Force, and the Missile Defense Agency, as well as non-military end users such as NASA and the Department of Homeland Security.
"I am proud to have this innovative team join our growing list of companies working together to prevent counterfeit infiltration," stated Janice Meraglia, Vice President of Government and Military Programs at Applied DNA Sciences. "Each thought leader that joins this critical effort to secure the defense supply chain sends a strong message: end users are taking matters into their own hands to ensure they provide the war fighters with as much protection as the war fighters provide to each and every one of us," continued Janice.
Dr. James A. Hayward, CEO and President, Applied DNA Sciences stated, "Each additional participant in the DNA marking program brings with them their own excellence in technological innovation and buoys the 'can do' spirit Applied DNA Sciences embodies. We believe this leader can help expand our SigNature DNA technology platform and elevate it to the next level. The risk of counterfeit parts in the electronics supply chain is a threat we have always taken seriously, and we will work diligently to support this Prime and encourage them to flow SigNature DNA marking across their entire enterprise and to pull the technology through their own suppliers and subcontractors," commented Dr. Hayward.
"We are a biotechnology company selling security products," continued Dr. Hayward, "and it is important that our investors appreciate that in some cases, we must protect the identity of our customers and partners. That is true in this case."
About Applied DNA Sciences
APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prevent crime.
The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 20, 2012 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.